Alterola Biotech Inc is a pioneering brand in the field of cannabinoid medicine. Their mission is to provide better medicines to patients worldwide by harnessing the therapeutic potential of cannabinoids and cannabinoid-like compounds. They believe that these compounds hold valuable treatments for seriously ill patients.

Unlike other companies, Alterola takes a comprehensive approach to identify, research, and create medicines by exploring botanical, traditional chemical synthesis, and biosynthetic methodologies. The company, through its subsidiary ABTI Pharma, aims to develop molecules that address unmet medical needs and improve treatments for various conditions. Their expertise allows them to utilize multiple technologies to develop a robust product pipeline, including the development of innovative, IP-protected molecules, lowering the Cost of Goods (CoGs), and improving drug delivery.

Join Alterola Biotech Inc in their mission to revolutionize cannabinoid medicine and bring hope to patients in need